What does PHARMACIE BEGON - VANDYCK do?

PHARMACIE BEGON - VANDYCK is a pharmacy in Mouscron. Private Limited, started on 11 December 1975, 1 establishment.

What is the address of PHARMACIE BEGON - VANDYCK?

The registered office of PHARMACIE BEGON - VANDYCK is located at Menenstraat 436, 7700 Mouscron.

Is PHARMACIE BEGON - VANDYCK still active?

Yes. According to the CBE (30 October 2026) PHARMACIE BEGON - VANDYCK is active, legal situation “Normale toestand”, started on 11 December 1975.

Is PHARMACIE BEGON - VANDYCK registered on Peppol?

Yes, PHARMACIE BEGON - VANDYCK is registered on the Peppol network with ID 0208:0415577890.

What is the enterprise number of PHARMACIE BEGON - VANDYCK?

The enterprise number of PHARMACIE BEGON - VANDYCK is BE0415577890.

When was PHARMACIE BEGON - VANDYCK founded?

PHARMACIE BEGON - VANDYCK was founded on 11 December 1975.

Who are the directors of PHARMACIE BEGON - VANDYCK?

According to the 2025 annual accounts, the directors of PHARMACIE BEGON - VANDYCK are: Caroline VANDYCK, Marie BEGON.

Is PHARMACIE BEGON - VANDYCK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 December 1975; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE BEGON - VANDYCK make in 2025?

PHARMACIE BEGON - VANDYCK posted a profit after taxes of € 109,377 in financial year 2025.

What is the revenue of PHARMACIE BEGON - VANDYCK?

As a small company, PHARMACIE BEGON - VANDYCK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 354,899.

How much does an employee at PHARMACIE BEGON - VANDYCK earn?

The average wage cost per full-time employee at PHARMACIE BEGON - VANDYCK was € 59,100 in 2025: staff costs of € 141,791 for 2.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE BEGON - VANDYCK have?

According to the 2025 annual accounts, PHARMACIE BEGON - VANDYCK has 2.4 full-time equivalents (FTE).

PHARMACIE BEGON - VANDYCK (Private Limited) - Mouscron

Dossier PHARMACIE BEGON - VANDYCK, printed on 30 October 2026 from databakkes.be/en/0415577890/pharmacie-begon-vandyck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE BEGON - VANDYCK from Mouscron, company number BE0415577890, closed financial year 2025 with a result of € 109,377 after tax. For that financial year PHARMACIE BEGON - VANDYCK recorded a gross margin of € 354,899 and equity of € 460,434. Compared with financial year 2024, the result moved from € 97,554 to € 109,377. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 460,434

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 109,377

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 185,131

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 79,136 paid out

72 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

2.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 141,791

▲ 2% vs 2024

€ 59,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 31,974

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 247,044

▼ 18% vs 2024

€ 49,896 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 30,894

▼ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 64,007

▲ 34% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 241,192 Gross margin 2022: € 241,192 First fiscal year in the series	€ 307,845 Gross margin 2023: € 307,845 ▲ 28% vs 2022 (€ 241,192) Favourable step	€ 352,340 Gross margin 2024: € 352,340 ▲ 14% vs 2023 (€ 307,845) Favourable step	€ 354,899 Gross margin 2025: € 354,899 ▲ 1% vs 2024 (€ 352,340) Favourable step	▲ 1%
Profit after taxes	€ 63,316 Profit after taxes 2022: € 63,316 First fiscal year in the series	€ 79,381 Profit after taxes 2023: € 79,381 ▲ 25% vs 2022 (€ 63,316) Favourable step	€ 97,554 Profit after taxes 2024: € 97,554 ▲ 23% vs 2023 (€ 79,381) Favourable step	€ 109,377 Profit after taxes 2025: € 109,377 ▲ 12% vs 2024 (€ 97,554) Favourable step	▲ 12%
Equity	€ 418,166 Equity 2022: € 418,166 First fiscal year in the series	€ 497,547 Equity 2023: € 497,547 ▲ 19% vs 2022 (€ 418,166) Favourable step	€ 430,193 Equity 2024: € 430,193 ▼ 14% vs 2023 (€ 497,547) Unfavourable step	€ 460,434 Equity 2025: € 460,434 ▲ 7% vs 2024 (€ 430,193) Favourable step	▲ 7%
Total debts	€ 528,878 Total debts 2022: € 528,878 First fiscal year in the series	€ 455,638 Total debts 2023: € 455,638 ▼ 14% vs 2022 (€ 528,878) Favourable step	€ 552,636 Total debts 2024: € 552,636 ▲ 21% vs 2023 (€ 455,638) Unfavourable step	€ 419,803 Total debts 2025: € 419,803 ▼ 24% vs 2024 (€ 552,636) Favourable step	▼ 24%
Cash	€ 260,979 Cash 2022: € 260,979 First fiscal year in the series	€ 199,856 Cash 2023: € 199,856 ▼ 23% vs 2022 (€ 260,979) Unfavourable step	€ 279,325 Cash 2024: € 279,325 ▲ 40% vs 2023 (€ 199,856) Favourable step	€ 185,131 Cash 2025: € 185,131 ▼ 34% vs 2024 (€ 279,325) Unfavourable step	▼ 34%
Land & buildings	€ 407,846 Land & buildings 2022: € 407,846 First fiscal year in the series	€ 379,265 Land & buildings 2023: € 379,265 ▼ 7% vs 2022 (€ 407,846) Unchanged	€ 350,684 Land & buildings 2024: € 350,684 ▼ 8% vs 2023 (€ 379,265) Unchanged	€ 341,634 Land & buildings 2025: € 341,634 ▼ 3% vs 2024 (€ 350,684) Unchanged	▼ 3%
Retained profit	€ 399,566 Retained profit 2022: € 399,566 First fiscal year in the series	€ 478,947 Retained profit 2023: € 478,947 ▲ 20% vs 2022 (€ 399,566) Favourable step	€ 411,593 Retained profit 2024: € 411,593 ▼ 14% vs 2023 (€ 478,947) Unfavourable step	€ 441,834 Retained profit 2025: € 441,834 ▲ 7% vs 2024 (€ 411,593) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 164,908 Dividend 2024: € 164,908 Unchanged (€ 0) Unchanged	€ 79,136 Dividend 2025: € 79,136 ▼ 52% vs 2024 (€ 164,908) Unchanged	▼ 52%
Bank debt	€ 367,469 Bank debt 2022: € 367,469 First fiscal year in the series	€ 356,139 Bank debt 2023: € 356,139 ▼ 3% vs 2022 (€ 367,469) Favourable step	€ 300,044 Bank debt 2024: € 300,044 ▼ 16% vs 2023 (€ 356,139) Favourable step	€ 247,044 Bank debt 2025: € 247,044 ▼ 18% vs 2024 (€ 300,044) Favourable step	▼ 18%
Balance sheet total	€ 947,045 Balance sheet total 2022: € 947,045 First fiscal year in the series	€ 953,186 Balance sheet total 2023: € 953,186 ▲ 1% vs 2022 (€ 947,045) Unchanged	€ 982,829 Balance sheet total 2024: € 982,829 ▲ 3% vs 2023 (€ 953,186) Unchanged	€ 880,237 Balance sheet total 2025: € 880,237 ▼ 10% vs 2024 (€ 982,829) Unchanged	▼ 10%
Employees (FTE)	2.1 Employees (FTE) 2022: 2.1 First fiscal year in the series	2.4 Employees (FTE) 2023: 2.4 ▲ 0.3 vs 2022 (2.1) Unchanged	2.4 Employees (FTE) 2024: 2.4 Unchanged (2.4) Unchanged	2.4 Employees (FTE) 2025: 2.4 Unchanged (2.4) Unchanged

Key figures of PHARMACIE BEGON - VANDYCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE BEGON - VANDYCK?

What happened at PHARMACIE BEGON - VANDYCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 109,377 (▲ 12% vs 2024). Source: NBB ↗
2012 Caroline VANDYCK became a director. NBB
2012 Marie BEGON became a director. NBB
Jan 1, 1976 New establishment in Mouscron. KBO
Dec 11, 1975 Start of the company according to the CBE. KBO

In short

From € 63,316 profit in 2022 to € 109,377 profit in 2025.

Paid € 142,471 in corporate taxes since 2022.

Best year ever: 2025, with € 109,377 profit.

On average € 147,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Caroline VANDYCK Marie BEGON

IMMOLOEUF

PHARMACIE BEGON - VANDYCK

Behind PHARMACIE BEGON - VANDYCK are Caroline VANDYCK and Marie BEGON. Caroline VANDYCK is also behind IMMOLOEUF.

Directors

According to the 2025 annual accounts

Caroline VANDYCK

Director

Also active at: IMMOLOEUF

since 2012

Marie BEGON

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Menenstraat 436

7700 Mouscron

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0415.577.890

VAT number

BE 0415.577.890

Registered office

Menenstraat 436, 7700 Mouscron

Names & denominations

PHARMACIE BEGON - VANDYCK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 December 1975

Peppol

Active · Active since 13 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in drogisterijartikelen en onderhoudsproducten

Gespecialiseerde detailhandel in drogisterijartikelen en onderhoudsproducten

Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE BEGON - VANDYCK

Financials

What happened to PHARMACIE BEGON - VANDYCK?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions